Everpure shares rose 6.3% to $98.20 at the latest close. The latest filing shows a business growing quickly, with cash conversion moving in the opposite direction.
Revenue for the six months ended Aug. 2 reached $1.2 billion, up 37.7% from the comparable period. Operating income climbed from $4.9 million to $63.2 million, and net income rose 57.4% to $74.1 million. The profit lines improved, even as gross margin slipped 1.8 percentage points to 68.4%.
Then comes the less decorative part of the 10-Q: operating cash flow fell from $496.1 million to $43.8 million. Cash declined to $385.7 million, while accounts receivable rose 93.7% to $1.0 billion and inventory more than doubled to $106.3 million.
Everpure gives a specific explanation for the cash-flow change, pointing to operating assets and liabilities rather than a weaker profit result.
"The year-over-year decrease in net cash provided by operating activities was primarily driven by a decrease of $625.4 million from changes in operating assets and liabilities, partially offset by higher net income of $65.1 million and higher stock-based compensation of $68.2 million."
10-Q 2026-09-04
That is a large swing in the cash engine during a period when revenue expanded by nearly two-fifths. The company does not break the $625.4 million change into each balance-sheet account in the supplied disclosure, but the reported receivables and inventory movements show where the working-capital pressure sits.
Management ties the operating-assets movement to customer demand and component availability, not to an unexplained accounting wrinkle.
"The decrease from changes in operating assets and liabilities were primarily impacted by strategic component purchases to support customer demand and secure component supply to support the growth of our business."
10-Q 2026-09-04
The plain-English translation is not that demand disappeared. It is that supporting demand required more cash tied up in the business. Capital spending also rose 26.3% to $169.7 million, while research and development increased 21.4% to $293.7 million.
The margin detail adds another layer. Everpure says lower intangible-asset amortization and royalties from hyperscaler shipments helped product gross margin, while higher component pricing pushed the other way. R&D expense rose with headcount and employee costs, including stock-based compensation, which increased 36.1% to $159.8 million.
The longer record makes the growth familiar rather than isolated. Annual revenue reached $3.7 billion in the year ended Feb. 1, up 15.6%, while net margin reached 5.1%. The latest six-month revenue growth is considerably faster, but the cash-flow conversion is moving in the opposite direction.
At 179.0 times latest annual earnings, the stock price puts a high numerical label on that growth. The filing does not settle whether the working-capital investment converts back into cash or becomes a recurring feature of expansion. Everpure's next quarterly report will provide the next comparison for operating cash flow and changes in operating assets and liabilities.
Everpure is growing quickly; the cash conversion of that growth is still unresolved.
Source: Everpure 10-Q filed Sept. 4, 2026, for the six months ended Aug. 2, 2026.